AI assistant
WEST PHARMACEUTICAL SERVICES INC — Director's Dealing 2015
May 18, 2015
30339_dirs_2015-05-18_6ab4700f-14b1-4574-95c5-0250c248fb47.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: WEST PHARMACEUTICAL SERVICES INC (WST)
CIK: 0000105770
Period of Report: 2015-05-14
Reporting Person: MOREL DONALD E JR (Chair of the Board & CEO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2015-05-14 | Common Stock | S | 10000.0000 | $54.4449 | Disposed | 804186.8917 | Direct |
| 2015-05-15 | Common Stock | S | 10000.0000 | $54.1260 | Disposed | 794186.8917 | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 2709.7700 | Indirect |
| Common Stock | 24669.6400 | Indirect |
Footnotes
F1: The price reported in Column 4 is an average price. These shares were sold in multiple transactions at prices ranging from $54.325 to $54.59, inclusive. The reporting person undertakes to provide to West Pharmaceutical Services, Inc., any security holder of West Pharmaceutical Services, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range in this footnote.
F2: The price reported in Column 4 is an average price. These shares were sold in multiple transactions at prices ranging from $53.93 to $54.58, inclusive. The reporting person undertakes to provide to West Pharmaceutical Services, Inc., any security holder of West Pharmaceutical Services, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range in this footnote.